Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Tarnow

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
Diabetes|April 28, 2005
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort studyPeter Hovind, Troels Krarup Hansen, Lise Tarnow, et al.
Kidney International|September 17, 2005
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathySylvia Schön, Christian Prante, Sandra Müller, et al.
Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2008
Elevated levels of high-molecular-weight adiponectin in type 1 diabetesHenrik Leth, Kristian K Andersen, Jan Frystyk, et al.
Diabetes Technology & Therapeutics|May 2, 2013
Real-time hypoglycemia detection from continuous glucose monitoring data of subjects with type 1 diabetesMorten Hasselstrøm Jensen, Toke Folke Christensen, Lise Tarnow, et al.
Journal of Diabetes Science and Technology|February 27, 2013
Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detectionMorten Hasselstrøm Jensen, Toke Folke Christensen, Lise Tarnow, et al.
Plos One|August 15, 2014
Model study of the pressure build-up during subcutaneous injectionMaria Thomsen, Anier Hernandez-Garcia, Joachim Mathiesen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2008
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patientsGowsini Joseph, Lise Tarnow, Anne Sofie Astrup, et al.
Diabetes|November 30, 2006
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes Care|October 9, 2010
Osteoprotegerin and mortality in type 2 diabetic patientsHenrik Reinhard, Maria Lajer, Mari-Anne Gall, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
Diabetes|April 28, 2005
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort studyPeter Hovind, Troels Krarup Hansen, Lise Tarnow, et al.
Kidney International|September 17, 2005
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathySylvia Schön, Christian Prante, Sandra Müller, et al.
Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2008
Elevated levels of high-molecular-weight adiponectin in type 1 diabetesHenrik Leth, Kristian K Andersen, Jan Frystyk, et al.
Diabetes Technology & Therapeutics|May 2, 2013
Real-time hypoglycemia detection from continuous glucose monitoring data of subjects with type 1 diabetesMorten Hasselstrøm Jensen, Toke Folke Christensen, Lise Tarnow, et al.
Journal of Diabetes Science and Technology|February 27, 2013
Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detectionMorten Hasselstrøm Jensen, Toke Folke Christensen, Lise Tarnow, et al.
Plos One|August 15, 2014
Model study of the pressure build-up during subcutaneous injectionMaria Thomsen, Anier Hernandez-Garcia, Joachim Mathiesen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2008
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patientsGowsini Joseph, Lise Tarnow, Anne Sofie Astrup, et al.
Diabetes|November 30, 2006
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes Care|October 9, 2010
Osteoprotegerin and mortality in type 2 diabetic patientsHenrik Reinhard, Maria Lajer, Mari-Anne Gall, et al.
Pageof 19